Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Michael U. Callaghan, MD
Healthcare Provider Director
Sickle Cell Center
Children's Hospital of Michigan
3901 Beaubien St.
Detroit, Michigan, United States
Michael U. Callaghan, MD, is Associate Professor of Pediatric Hematology/Oncology at Wayne State University School of Medicine and Director of the Sickle Cell Center at the Children’s Hospital of Michigan. He received his medical degree from Wayne State University, and completed his pediatric residency and pediatric hematology/oncology fellowship at Children’s Hospital of Michigan.
Dr. Callaghan cares for more than 100 children and adults with hemophilia and has served as Medical Director of Camp Bold Eagle hemophilia camp. He participates in basic, translational, and clinical research. Dr. Callaghan has authored or coauthored over 50 peer-reviewed articles that have been published in journals such as Haemophilia, Blood, Nature Genetics, and The New England Journal of Medicine. He is the previous recipient of the John Penner Award from the Hemophilia Foundation of Michigan and has been featured in Top Doctors in America.
Clinical interests:
Bleeding Disorders
Hemophilia and its Complications
von Willebrand Disease ITP and other immune cytopenias
Polycythemia
Congenital bone marrow failure
Sickle cell disease
Hemoglobinopathies
Research interests:
Clotting factor inhibitors
New Coagulation
Unfolded Protein Response
Translational hematology and early clinical trials with emphasis on drug discovery
Sickle cell disease
Hemoglobinopathies
+myBinderRelated Content
-
10 Tips to Get the Most Out of Your Health Insurance Tip SheetAs we all know, healthcare can be expens...
-
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful CrisesOBJECTIVES: Sickle cell disease is the ...
-
4 Transition Stages of Sickle Cell Disease and Tips for Each Stagehttps://www.onescdvoice.com/wp-content/u...
-
Sophie Lanzkron, MD, MHSDr. Sophie Lanzkron is an associate prof...
-
Nadine Matthie, PhD, RNNadine Matthie is an assistant professor...
-
Sickle Cell Disease Association of America, Inc.SCDAA provides leadership on a national ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
